Top Story

Going Public Soon: Next Major Step for Gage Growth Corp.
April 5th, 2021 - Robin Lefferts
The public markets have sometimes been good for cannabis companies, sometimes not so much. A look at trailing twelve month performance of two leading industry ETFs, an easy wa...
Top News

Psychedelics Wellness Company Delic: Proven Management Team with a Star-Studded Board
April 9th, 2021 - Ryan Allway

Gage Cannabis Announces Exclusive Partnership With Blue River™ to Bring Award-Winning Cannabis Extracts to Michigan
April 8th, 2021 - Ryan Allway

Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology
April 7th, 2021 - Ryan Allway

Next Green Wave Announces Record Monthly Adjusted EBITDA
April 6th, 2021 - Ryan Allway
Public Companies
Private Companies & Entrepreneurs
Cannabis & CBD

Canopy Growth to Acquire The Supreme Cannabis Company
April 8th, 2021 - Ryan Allway

SpeakEasy Reports Earnings for it’s First Quarter of Sales and Releases Quarter Two Financial Results
April 8th, 2021 - Ryan Allway

Pure Extracts to Enter US Market through JV in Michigan
April 8th, 2021 - Ryan Allway

Gage Cannabis Announces Exclusive Partnership With Blue River™ to Bring Award-Winning Cannabis Extracts to Michigan
April 8th, 2021 - Ryan Allway

Ikänik Farms Enters Into Three Year Supply Contract With Yura Group
April 7th, 2021 - Ryan Allway

Cannara Biotech Commences Trading on TSXV on April 8, 2021
April 7th, 2021 - Ryan Allway

BioHarvest Sciences Inc. Delivers Record First Quarter Sales Performance of VINIA in Israel
April 7th, 2021 - Ryan Allway

Heritage Cannabis Set to Initiate U.S. Product Launch Through Relationship With Merida Capital Holdings
April 7th, 2021 - Ryan Allway
Psychedelics & Mushrooms

Psychedelics Wellness Company Delic: Proven Management Team with a Star-Studded Board
April 9th, 2021 - Ryan Allway

Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division
April 8th, 2021 - Ryan Allway

Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic Technology
April 7th, 2021 - Ryan Allway

NeonMind Developing Music Playlist For Psychedelic Therapy Sessions
April 6th, 2021 - Ryan Allway

Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
April 6th, 2021 - Ryan Allway

Core One Labs Vocan Expands Product Commercialization Team
April 6th, 2021 - Ryan Allway

Optimi Health Aims to Expand its Shareholder Base
April 6th, 2021 - Ryan Allway
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer